3D imaging of the mitochondrial redox state of rat hearts under normal and fasting conditions

He N. Xu; Rong Zhou; Lily Moon; Min Feng; Lin Z. Li

doi:10.1142/s1793545813500454

[1] H. G. Zimmer, "Some aspects of cardiac heterogeneity," Basic Res. Cardiol. 89, 101–117 (1994).

[2] A. R. Pries, T. W. Secomb, "Origins of heterogeneity in tissue perfusion and metabolism," Cardiovasc. Res. 81, 328–335 (2009).

[3] R. S. Balaban, A. Arai, "Function, metabolic, and flow heterogeneity of the heart: The view is getting better," Circ. Res. 88, 265–267 (2001).

[4] A. Deussen, T. Lauer, R. Loncar, J. Kropp, "Heterogeneity of metabolic parameters in the left ventricular myocardium and its relation to local blood flow," Basic Res. Cardiol. 96, 564–574 (2001).

[5] U. K. Decking, J. Schrader, "Spatial heterogeneity of myocardial perfusion and metabolism," Basic Res. Cardiol. 93, 439–445 (1998).

[6] E. D. Lewandowski, "Metabolic heterogeneity of carbon substrate utilization in mammalian heart: NMR determinations of mitochondrial versus cytosolic compartmentation," Biochemistry 31, 8916– 8923 (1992).

[7] A. Mayevsky, "Shedding light on life: Optical assessment of mitochondrial function and tissue vitality in biology and medicine," J. Innov. Opt. Health Sci. 1, 71–83 (2008).

[8] A. Mayevsky, B. Chance, "Oxidation-reduction states of NADH in vivo: From animals to clinical use," Mitochondrion 7, 330–339 (2007).

[9] A. Mayevsky, G. G. Rogatsky, "Mitochondrial function in vivo evaluated by NADH fluorescence: from animal models to human studies," Am. J. Physiol. Cell Physiol. 292, C615–C640 (2007).

[10] C. Ince, J. F. Ashruf, J. A. Avontuur, P. A. Wieringa, J. A. Spaan, H. A. Bruining, "Heterogeneity of the hypoxic state in rat heart is determined at capillary level," Am. J. Physiol. Heart Circ. Physiol. 264, H294–H301 (1993).

[11] C. Steenbergen, G. Deleeuw, C. Barlow, B. Chance, J. R. Williamson, "Heterogeneity of the hypoxic state in perfused rat heart," Circ. Res. 41, 606–615 (1977).

[12] C. Steenbergen, J. R. Williamson, "Heterogeneous coronary perfusion during myocardial hypoxia," Adv. Myocardiol. 2, 271–284 (1980).

[13] C. Steenbergen, G. Deleeuw, J. R. Williamson, "Analysis of control of glycolysis in ischemic hearts having heterogeneous zones of anoxia," J. Mol. Cell Cardiol. 10, 617–639 (1978).

[14] J. R. Williamson, K. N. Davis, G. Medina-Ramirez, "Quantitative analysis of heterogenous NADH fluorescence in perfused rat hearts during hypoxia and ischemia," J. Mol. Cell Cardiol. 14, 29–35 (1982).

[15] J. F. Ashruf, C. Ince, H. A. Bruining, "Regional ischemia in hypertrophic Langendorff-perfused rat hearts," Am. J. Physiol. 277, H1532–H1539 (1999).

[16] A. H. Harken, C. H. Barlow, W. R. Harden, 3rd, B. Chance, "Two and three dimensional display of myocardial ischemic "border zone" in dogs," Am. J. Cardiol. 42, 954–959 (1978).

[17] C. H. Barlow, B. Chance, "Ischemic areas in perfused rat hearts: Measurement by NADH fluorescence photography," Science 193, 909–910 (1976).

[18] C. H. Barlow, W. R. Harden, 3rd, A. H. Harken, M. B. Simson, J. C. Haselgrove, B. Chance, M. O'Connor, G. Austin, "Fluorescence mapping of mitochondrial redox changes in heart and brain," Crit. Care Med. 7, 402–406 (1979).

[19] B. Chance, C. Barlow, J. Haselgrove, Y. Nakase, B. Quistorff, F. Matschinsky, A. Mayevsky, "Microheterogeneities of redox states of perfused and intact organs," in Microenvironments and Metabolic Compertmentation, P. A. Srere, R. W. Estabrook, Eds., pp. 131–148, Academic Press (1978).

[20] R. J. Bing, "Cardiac metabolism," Physiol. Rev. 45, 171–213 (1965).

[21] W. C. Stanley, "Changes in cardiac metabolism: A critical step from stable angina to ischaemic cardiomyopathy," Eur. Heart J. Suppl. 3, O2–O7 (2001).

[22] G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal, W. C. Stanley, "Myocardial fatty acid metabolism in health and disease," Physiol. Rev. 90, 207–258 (2010).

[23] G. D. Lopaschuk, D. D. Belke, J. Gamble, T. Itoi, B. O. Schonekess, "Regulation of fatty acid oxidation in the mammalian heart in health and disease," Biochim. Biophys. Acta 1213, 263–276 (1994).

[24] J. R. Neely, H. E. Morgan, "Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle," Ann. Rev. Physiol. 36, 413–459 (1974).

[25] L. Mouchiroud, R. H. Houtkooper, J. Auwerx, "NADt metabolism: A therapeutic target for agerelated metabolic disease," Crit. Rev. Biochem. Mol. Biol. 48, 397–408 (2013).

[26] S. J. Lin, E. Ford, M. Haigis, G. Liszt, L. Guarente, "Calorie restriction extends yeast life span by lowering the level of NADH," Genes Dev. 18, 12–16 (2004).

[27] D. Chen, J. Bruno, E. Easlon, S. J. Lin, H. L. Cheng, F. W. Alt, L. Guarente, "Tissue-specific regulation of SIRT1 by calorie restriction," Genes Dev. 22, 1753–1757 (2008).

[28] M. P. Mattson, R. Wan, "Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems," J. Nutr. Biochem. 16, 129–137 (2005).

[29] S. Schaefer, R. Ramasamy, "Glycogen utilization and ischemic injury in the isolated rat heart," Cardiovasc. Res. 35, 90–98 (1997).

[30] T. Doenst, P. H. Guthrie, J. M. Chemnitius, R. Zech, H. Taegtmeyer, "Fasting, lactate, and insulin improve ischemia tolerance in rat heart: A comparison with ischemic preconditioning," Am. J. Physiol. 270, H1607–H1615 (1996).

[31] G. W. Goodwin, H. Taegtmeyer, "Metabolic recovery of isolated working rat heart after brief global ischemia," Am. J. Physiol. 267, H462–H470 (1994).

[32] C. A. Schneider, H. Taegtmeyer, "Fasting in vivo delays myocardial cell damage after brief periods of ischemia in the isolated working rat heart," Circ. Res. 68, 1045–1050 (1991).

[33] L. F. Wang, R. Ramasamy, S. Schaefer, "Regulation of glycogen utilization in ischemic hearts after 24 hours of fasting," Cardiovasc. Res. 42, 644–650 (1999).

[34] B. Chance, B. Schoener, R. Oshino, F. Itshak, Y. Nakase, "Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals," J. Biol. Chem. 254, 4764–4771 (1979).

[35] Y. Gu, Z. Qian, J. Chen, D. Blessington, N. Ramanujam, B. Chance, "High-resolution three-dimensional scanning optical image system for intrinsic and extrinsic contrast agents in tissue," Rev. Sci. Instrum. 73, 172–178 (2002).

[36] B. Quistorff, J. C. Haselgrove, B. Chance, "High spatial resolution readout of 3-D metabolic organ structure: An automated, low-temperature redox ratio-scanning instrument," Anal. Biochem. 148, 389–400 (1985).

[37] L. Z. Li, H. N. Xu, M. Ranji, S. Nioka, B. Chance, "Mitochondrial redox imaging for cancer diagnostic and therapeutic studies," J. Innov. Opt. Health Sci. 2, 325–341 (2009).

[38] H. N. Xu, S. Nioka, B. Chance, L. Z. Li, "Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model," Biomark. Res. 1, 6 (2013).

[39] K. Ozawa, B. Chance, A. Tanaka, S. Iwata, T. Kitai, I. Ikai, "Linear correlation between acetoacetate/ beta-hydroxybutyrate in arterial blood and oxidized flavoprotein/reduced pyridine nucleotide in freeze-trapped human liver tissue," Biochim. Biophys. Acta. 1138, 350–352 (1992).

[40] K. Sato, Y. Kashiwaya, C. A. Keon, N. Tsuchiya, M. T. King, G. K. Radda, B. Chance, K. Clarke, R. L. Veech, "Insulin, ketone bodies, and mitochondrial energy transduction," FASEB J. 9, 651– 658 (1995).

[41] H. N. Xu, S. Nioka, J. D. Glickson, B. Chance, L. Z. Li, "Quantitative mitochondrial redox imaging of breast cancer metastatic potential," J. Biomed. Opt. 15, 036010 (2010).

[42] H. N. Xu, B. Wu, S. Nioka, B. Chance, L. Z. Li, "Quantitative redox scanning of tissue samples using a calibration procedure," J. Innov. Opt. Health Sci. 2, 375–385 (2009).

[43] H. N. Xu, B. Wu, S. Nioka, B. Chance, L. Z. Li. Calibration of redox scanning for tissue samples, Proc. SPIE Optical Tomography and Spectroscopy of Tissue VIII 7174, p. 71742F1-8 (2009).

[44] E. M. Nuutinen, "Subcellular origin of the surface fluorescence of reduced nicotinamide nucleotides in the isolated perfused rat heart," Basic Res. Cardiol. 79, 49–58 (1984).

[45] L. A. Katz, A. P. Koretsky, R. S. Balaban, "Respiratory control in the glucose perfused heart. A 31P NMR and NADH fluorescence study," FEBS Lett. 221, 270–276 (1987).

[46] R. W. Estabrook, "Fluorometric measurement of reduced pyridine nucleotide in cellular and subcellular particles," Anal. Biochem. 4, 231–245 (1962).

[47] M. Klingenberg, W. Slenczka, E. Ritt, "Comparative biochemistry of the pyridine nucleotide system in the mitochondria of various organs," Biochem. Z 332, 47–66 (1959).

[48] J. Eng, R. M. Lynch, R. S. Balaban, "Nicotinamide adenine dinucleotide fluorescence spectroscopy and imaging of isolated cardiac myocytes," Biophys. J 55, 621–630 (1989).

[49] K. Blinova, R. L. Levine, E. S. Boja, G. L. Griffiths, Z. D. Shi, B. Ruddy, R. S. Balaban, "Mitochondrial NADH fluorescence is enhanced by Complex I binding," Biochemistry 47, 9636–9645 (2008).

[50] I. Hassinen, B. Chance, "Oxidation-reduction properties of the mitochondrial flavoprotein chain," Biochem. Biophys. Res. Commun. 31, 895–900 (1968).

[51] W. S. Kunz, W. Kunz, "Contribution of different enzymes to flavoprotein fluorescence of isolated rat liver mitochondria," Biochim. Biophys. Acta 841, 237–246 (1985).

[52] L. Z. Li, "Imaging mitochondrial redox potential and its possible link to tumor metastatic potential," J. Bioenerg. Biomembr. 44, 645–653 (2012).

[53] B. Ware, M. Bevier, Y. Nishijima, S. Rogers, C. A. Carnes, V. A. Lacombe, "Chronic heart failure selectively induces regional heterogeneity of insulinresponsive glucose transporters," Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R1300–R1306 (2011).

[54] A. L. Lehninger, D. L. Nelson, M. M. Cox, Principles of Biochemistry, Worth Publishers, New York (1993).

[55] G. J. van der Vusse, J. F. Glatz, H. C. Stam, R. S. Reneman, "Fatty acid homeostasis in the normoxic and ischemic heart," Physiol. Rev. 72, 881–940 (1992).

[56] J. F. Oram, S. L. Bennetch, J. R. Neely, "Regulation of fatty acid utilization in isolated perfused rat hearts," J. Biol. Chem. 248, 5299–5309 (1973).

[57] W. S. Kunz, "Application of the theory of steadystate flux control to mitochondrial beta-oxidation," Biomed. Biochim. Acta 50, 1143–1157 (1991).

[58] S. Eaton, "Control of mitochondrial beta-oxidation flux," Prog. Lipid Res. 41, 197–239 (2002).

[59] H. N. Xu, B. Wu, S. Nioka, B. Chance, L. Z. Li. Calibration of CCD-based redox imaging for biological tissues, Proc. SPIE Medical Imaging 2009: Biomedical Applications in Molecular, Structural, and Functional Imaging 7262, p. 72622F1-7 (2009).

[60] R. Sepehr, K. Staniszewski, S. Maleki, E. R. Jacobs, S. Audi, M. Ranji, "Optical imaging of tissue mitochondrial redox state in intact rat lungs in two models of pulmonary oxidative stress," J. Biomed. Opt. 17, 046010 (2012).